{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:39:51Z","timestamp":1791074391071,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T00:00:00Z","timestamp":1123200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold>Cyclophosphamide (CPA) is widely used in chemotherapy. The CPA is a prodrug that requires metabolic transformation to generate the active metabolite, 4\u2010hydroxy\u2010CPA (4\u2010OH\u2010CPA). Ciprofloxacin (CF) is a fluoroquinolone antibiotic with a broad spectrum that is commonly used in treatment of a variety of infections. It has been reported that prophylactic administration of CF during CPA conditioning was a high\u2010risk factor for relapse in patients undergoing allogeneic bone marrow transplantation. In the present study we investigated the pharmacokinetics of CPA and 4\u2010OH\u2010CPA in eight non\u2010Hodgkin lymphoma (NHL) patients treated with CPA together with or without CF. Clearance and distribution volumes of CPA were significantly (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) lower (4.7\u2003L\/h and 42.3\u2003L, respectively) when patients were treated with CF prior to CPA compared to that observed when the patients did not receive CF (5.9\u2003L\/h and 48.1\u2003L, respectively). No change in the elimination half\u2010life was observed. The CF administration prior to CPA has resulted in significantly (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) lower exposure to 4\u2010OH\u2010CPA as expressed as area under the plasma concentration curve (AUC). The metabolic ratio AUC<jats:sub>4\u2010OH\u2010CPA<\/jats:sub>\/AUC<jats:sub>CPA<\/jats:sub>was lower in all patients treated with CF prior to CPA compared to that observed when patients received CPA only (<jats:italic>P<\/jats:italic>\u2003=\u20030.008). Our study showed that CF administration alters CPA kinetics in patients with NHL. Other antibiotics than these contain fluoroquinolones should be used during CPA therapy.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2005.00492.x","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T16:26:59Z","timestamp":1123259219000},"page":"206-211","source":"Crossref","is-referenced-by-count":8,"title":["The effect of ciprofloxacin on cyclophosphamide pharmacokinetics in patients with non\u2010Hodgkin lymphoma"],"prefix":"10.1111","volume":"75","author":[{"given":"Parvaneh","family":"Afsharian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"M\u00f6llg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kimby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,5]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073353"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(88)90004-6"},{"key":"e_1_2_6_4_2","first-page":"414","article-title":"Interindividual variations in human liver cytochrome P\u2010450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada T","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_5_2","first-page":"928","article-title":"In vivo modulation of alternative pathways of P\u2010450\u2010catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity","volume":"288","author":"Yu LJ","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_6_2","first-page":"4229","article-title":"Oxidation of cyclophosphamide to 4\u2010hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes","volume":"57","author":"Ren S","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_7_2","first-page":"5629","article-title":"Differential activation of cyclophosphamide and ifosfamide by cytochromes P\u2010450 2B and 3A in human liver microsomes","volume":"53","author":"Chang TK","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01966994"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_3.S495"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.5.784"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.suppl_A.25"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1989.01860330053016"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90249-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/22.Supplement_C.109","article-title":"Interaction between the fluoroquinolones and the bronchodilator theophylline","volume":"22","author":"Wijnands WJ","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90247-X"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90031-4"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archinte.1991.00400050139027","article-title":"Adverse reaction reporting of interaction between warfarin and fluoroquinolones","volume":"151","author":"Jolson HM","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_18_2","first-page":"1134","article-title":"Fluoroquinolone antibiotics inhibit cytochrome P450\u2010mediated microsomal drug metabolism in rat and human","volume":"24","author":"McLellan RA","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1399-0012.1998.tb01074.x","article-title":"Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination","volume":"12","author":"Carlens S","year":"1998","journal-title":"Clin Transplant"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703815"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-100101942"},{"key":"e_1_2_6_22_2","first-page":"92","article-title":"Lymphomas: Hodgkin and non\u2010Hodgkin lymphomas","volume":"28","author":"Federico M","year":"2004","journal-title":"Epidemiol Prev"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100358"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809057571"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(94)00283-5"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200206000-00013"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800000132"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.10.008"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-002-0482-y"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0753-2"},{"key":"e_1_2_6_31_2","first-page":"544","article-title":"Nonlinear pharmacokinetics of cyclophosphamide and 4\u2010hydroxycyclophosphamide\/aldophosphamide in patients with metastatic breast cancer receiving high\u2010dose chemotherapy followed by autologous bone marrow transplantation","volume":"25","author":"Chen TL","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1484"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1999.tb01764.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.6.995"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2005.00492.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2005.00492.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:53:08Z","timestamp":1735876388000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2005.00492.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1600-0609.2005.00492.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2005.00492.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,5]]}}}